# Spectra Breast Implant Study

> **NCT00981266** · PHASE3 · WITHDRAWN · sponsor: **Mentor Worldwide, LLC**

## Conditions studied

- Augmentation
- Augmentation Revision
- General Breast Enlargement
- Post-lactational Involution
- Asymmetry

## Interventions

- **DEVICE:** Mentor Spectra/Becker 80 Breast Implant

## Key facts

- **NCT ID:** NCT00981266
- **Lead sponsor:** Mentor Worldwide, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-06
- **Primary completion:** 2024-01
- **Final completion:** 2026-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Business decision. Study never started
- **Last updated:** 2013-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00981266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00981266, "Spectra Breast Implant Study". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00981266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*